Target intelligence / Profile preview

KANK1 antisense RNA 1 (KANK1-AS1)

Target
KANK1-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

KANK1 antisense RNA 1 (KANK1-AS1) is a human long non-coding RNA transcribed antisense to the KANK1 gene. Like other antisense lncRNAs, it may function in the epigenetic and post-transcriptional regulation of its sense partner gene or others, possibly controlling gene expression, cell proliferation, or apoptosis indirectly[2][3][9]. However, specific biological functions, disease associations, drug interactions, and clinical utility of KANK1-AS1 remain largely uncharacterized in current literature, and no direct evidence exists for its use as a therapeutic target at this time[9]. If you need information about KANK1 (KN motif and ankyrin repeat domains 1), the protein-coding gene, or its roles in cancer and cell biology, please clarify, as those aspects are well-documented and distinct from the antisense non-coding RNA[1][4][7][8][10].

02

Mechanism of action

Not applicable. No drugs with a known mechanism of action targeting KANK1-AS1 are documented

03

Biological functions

Regulation of gene expression (likely post-transcriptional and epigenetic modulation, consistent with the functions of other antisense lncRNAs)Potential influence on cell proliferation and apoptosis, based on analogies to similar antisense lncRNAs (direct evidence for KANK1-AS1 remains sparse)

Beyond the preview

Go deeper on KANK1 antisense RNA 1 (KANK1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on KANK1 antisense RNA 1 (KANK1-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call